NCT06356337Completed
A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1
Light Exposure Tracker in Alzheimer's Disease.
Source: ClinicalTrials.gov · Last updated 14 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this research study is to investigate the relationship between reminder messages sent via text and compliance with a daily morning light intervention designed to advance the circadian clock. Twenty healthy adults will be recruited to participate in a randomized, cross-over study where daily messages are, or are not, provided to remind participants to carry out the intervention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 4 Apr 2024
- Start date
- 22 Feb 2024
- Primary completion date
- 15 Aug 2024
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Diseases
- Alzheimer disease
- NCT number
- NCT06356337
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 22 Feb 2024 to the primary completion date, 15 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- use of sleep medications
Other illness
- restless leg syndrome
- brain disease
Other
- Severe sleep apnea
- obstructing cataracts
- macular degeneration
- diabetic retinopathy
- glaucoma
Who the study is looking for
- healthy adults over the age of 55
- score of 25 or greater on MoCA
Age in the registry: 55 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Light and Health Research Center Coordinator of this site? Confirm its status | Menands | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.